Shona Clegg

2.5k total citations · 2 hit papers
11 papers, 1.0k citations indexed

About

Shona Clegg is a scholar working on Psychiatry and Mental health, Neurology and Cognitive Neuroscience. According to data from OpenAlex, Shona Clegg has authored 11 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Psychiatry and Mental health, 4 papers in Neurology and 3 papers in Cognitive Neuroscience. Recurrent topics in Shona Clegg's work include Dementia and Cognitive Impairment Research (5 papers), Alzheimer's disease research and treatments (3 papers) and Functional Brain Connectivity Studies (2 papers). Shona Clegg is often cited by papers focused on Dementia and Cognitive Impairment Research (5 papers), Alzheimer's disease research and treatments (3 papers) and Functional Brain Connectivity Studies (2 papers). Shona Clegg collaborates with scholars based in United Kingdom, United States and Belgium. Shona Clegg's co-authors include Nick C. Fox, Kelvin K. Leung, Josephine Barnes, Gerard R. Ridgway, Ian B. Malone, Jennifer L. Whitwell, John Ashburner, Casper Nielsen, Sébastien Ourselin and Chris Frost and has published in prestigious journals such as The Lancet, NeuroImage and Neurology.

In The Last Decade

Shona Clegg

11 papers receiving 1.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Accurate automatic estimation of total intracranial volume: A nuisance variable with less nuisance

2014 305 citations Ian B. Malone, Kelvin K. Leung et al. NeuroImage profile →
Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial

2014 304 citations Jeremy Chataway, Nadine Schuerer et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shona Clegg United Kingdom	8	311	261	256	238	229	11	1.0k
Katja Petrovic Austria	16	298 1.0×	185 0.7×	162 0.6×	332 1.4×	228 1.0×	21	1.3k
Milan Arsić Germany	5	258 0.8×	244 0.9×	123 0.5×	160 0.7×	357 1.6×	5	1.1k
Vincent Planche France	19	264 0.8×	150 0.6×	282 1.1×	199 0.8×	328 1.4×	63	1.0k
Adriaan Versteeg Netherlands	17	339 1.1×	208 0.8×	262 1.0×	135 0.6×	265 1.2×	21	874
Marisa Loitfelder Austria	16	158 0.5×	293 1.1×	96 0.4×	295 1.2×	363 1.6×	17	1.2k
Blandine Grassiot France	10	323 1.0×	279 1.1×	274 1.1×	110 0.5×	94 0.4×	16	784
Muna Hoshi Germany	8	205 0.7×	231 0.9×	90 0.4×	167 0.7×	467 2.0×	9	1.2k
E. Bollen Netherlands	19	337 1.1×	391 1.5×	269 1.1×	385 1.6×	153 0.7×	28	1.5k
G Lenzi Italy	16	308 1.0×	170 0.7×	137 0.5×	181 0.8×	204 0.9×	36	943

Countries citing papers authored by Shona Clegg

Since Specialization

Citations

This map shows the geographic impact of Shona Clegg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shona Clegg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shona Clegg more than expected).

Fields of papers citing papers by Shona Clegg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shona Clegg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shona Clegg. The network helps show where Shona Clegg may publish in the future.

Co-authorship network of co-authors of Shona Clegg

This figure shows the co-authorship network connecting the top 25 collaborators of Shona Clegg. A scholar is included among the top collaborators of Shona Clegg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shona Clegg. Shona Clegg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Novak, Gerald, Nick C. Fox, Shona Clegg, et al.. (2015). Changes in Brain Volume with Bapineuzumab in Mild to Moderate Alzheimer’s Disease. Journal of Alzheimer s Disease. 49(4). 1123–1134. 38 indexed citations

Slattery, Catherine F., Ian B. Malone, Shona Clegg, Jason D. Warren, & Nick C. Fox. (2015). Reversible frontotemporal brain sagging syndrome. Neurology. 85(9). 833–833. 5 indexed citations

Chataway, Jeremy, Nadine Schuerer, Ali Alsanousi, et al.. (2014). Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial. The Lancet. 383(9936). 2213–2221. 304 indexed citations breakdown →

Malone, Ian B., Kelvin K. Leung, Shona Clegg, et al.. (2014). Accurate automatic estimation of total intracranial volume: A nuisance variable with less nuisance. NeuroImage. 104. 366–372. 305 indexed citations breakdown →

Chataway, Jeremy, Nadine Schuerer, Ali Alsanousi, et al.. (2013). THE MS-STAT TRIAL: High Dose Simvastatin Slows Brain Atrophy and Delays Disability in Secondary Progressive Multiple Sclerosis: A Phase II Placebo-Controlled Trial (PL02.001). Neurology. 80(7_supplement). 6 indexed citations

Einstein, Steven, Sylvain Bouix, Casper Nielsen, et al.. (2013). P1–335: The impact of gradient field distortion on the calculation of brain atrophy in Alzheimer's disease, derived from volumetric MRI using the boundary shift integral. Alzheimer s & Dementia. 9(4S_Part_7). 1 indexed citations

Mahoney, Colin, Laura Downey, Gerard R. Ridgway, et al.. (2012). Longitudinal neuroimaging and neuropsychological profiles of frontotemporal dementia with C9ORF72 expansions. Alzheimer s Research & Therapy. 4(5). 41–41. 80 indexed citations

Archer, Hilary, John Kennedy, Josephine Barnes, et al.. (2010). Memory complaints and increased rates of brain atrophy: risk factors for mild cognitive impairment and Alzheimer's disease. International Journal of Geriatric Psychiatry. 25(11). 1119–1126. 12 indexed citations

Leung, Kelvin K., Matthew J. Clarkson, Jonathan W. Bartlett, et al.. (2009). Robust atrophy rate measurement in Alzheimer's disease using multi-site serial MRI: Tissue-specific intensity normalization and parameter selection. NeuroImage. 50(2). 516–523. 115 indexed citations

10.

Evans, Matthew C., Josephine Barnes, Casper Nielsen, et al.. (2009). Volume changes in Alzheimer’s disease and mild cognitive impairment: cognitive associations. European Radiology. 20(3). 674–682. 87 indexed citations

11.

Rohrer, Jonathan D., Elizabeth McNaught, Shona Clegg, et al.. (2008). Tracking progression in frontotemporal lobar degeneration. Neurology. 71(18). 1445–1451. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact